Evidence map›Paper›PMID 21937992›Full record

ArticleNature2011

Deep sequencing reveals 50 novel genes for recessive cognitive disorders.

Hossein Najmabadi, Hao Hu, Masoud Garshasbi, Tomasz Zemojtel, Seyedeh Sedigheh Abedini, Wei Chen, Masoumeh Hosseini, Farkhondeh Behjati, Stefan Haas, Payman Jamali and 35 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 500 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
500citing papers in PubMed, 1 pooled it
46.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

500 citing papers in PubMed, 1 synthesis or guideline pooled it, 982 citations in OpenAlex.

  1. Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches.Tremor and other hyperkinetic movements (New York, N.Y.) · 2023
    Pooled it
  2. Article
  3. Appreciating diversity: a review of the Iranian genomic landscape.European journal of human genetics : EJHG · 2026
    Review
  4. Article
  5. Advances and clinical potential of epigenome editing.Cellular and molecular life sciences : CMLS · 2026
    Review
  6. Article
  7. NovelNeurology. Genetics · 2026
    Article
  8. Article
  9. Clinical spectrum and treatment responses in.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  10. Dysregulation of CD39/Ectonucleoside Triphosphate Diphosphohydrolase 1 Causes Urinary Bladder Dysfunction with Abnormal Smooth Muscle Contractility.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. NADScience advances · 2025
    Article

440 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

45 authors at 8 institutions in 4 countries.

Hossein NajmabadiGenetics Research Center, University of Social Welfare and Rehabilitation Sciences, 19857 Tehran, Iran.
Hao Hu
Masoud Garshasbi
Tomasz Zemojtel
Seyedeh Sedigheh Abedini
Wei Chen
Masoumeh Hosseini
Farkhondeh Behjati
Stefan Haas
Payman Jamali
Agnes Zecha
Marzieh Mohseni
Lucia Püttmann
Leyla Nouri Vahid
Corinna Jensen
Lia Abbasi Moheb
Melanie Bienek
Farzaneh Larti
Ines Mueller
Robert Weissmann
Hossein Darvish
Klaus Wrogemann
Valeh Hadavi
Bettina Lipkowitz
Sahar Esmaeeli-Nieh
Dagmar Wieczorek
Roxana Kariminejad
Saghar Ghasemi Firouzabadi
Monika Cohen
Zohreh Fattahi
Imma Rost
Faezeh Mojahedi
Christoph Hertzberg
Atefeh Dehghan
Anna Rajab
Mohammad Javad Soltani Banavandi
Julia Hoffer
Masoumeh Falah
Luciana Musante
Vera Kalscheuer
Reinhard Ullmann
Andreas Walter Kuss
Andreas Tzschach
Kimia Kahrizi
H Hilger Ropers
Max Planck Institute for Molecular Genetics · DEUniversity of Social Welfare and Rehabilitation Sciences · IRGerman Center for Pediatric and Adolescent Rheumatology · DEMax Delbrück Center · DERoyal Hospital · OMUniversity of Manitoba · CAVivantes Klinikum · DEYazd University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common diseases are often complex because they are genetically heterogeneous, with many different genetic defects giving rise to clinically indistinguishable phenotypes. This has been amply documented for early-onset cognitive impairment, or intellectual disability, one of the most complex disorders known and a very important health care problem worldwide. More than 90 different gene defects have been identified for X-chromosome-linked intellectual disability alone, but research into the more frequent autosomal forms of intellectual disability is still in its infancy. To expedite the molecular elucidation of autosomal-recessive intellectual disability, we have now performed homozygosity mapping, exon enrichment and next-generation sequencing in 136 consanguineous families with autosomal-recessive intellectual disability from Iran and elsewhere. This study, the largest published so far, has revealed additional mutations in 23 genes previously implicated in intellectual disability or related neurological disorders, as well as single, probably disease-causing variants in 50 novel candidate genes. Proteins encoded by several of these genes interact directly with products of known intellectual disability genes, and many are involved in fundamental cellular processes such as transcription and translation, cell-cycle control, energy metabolism and fatty-acid synthesis, which seem to be pivotal for normal brain development and function.

Indexed as

High-Throughput Nucleotide SequencingBrainCell CycleCognition DisordersConsanguinityDNA Mutational AnalysisExonsGene Regulatory NetworksGenes, EssentialGenes, RecessiveHomozygoteHumansIntellectual DisabilityMetabolic Networks and PathwaysMutationOrgan Specificity

Identifiers

PMID21937992
OpenAlexW2138196920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.